Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. Fox Chase Cancer Center, Philadelphia, PA, United States

Survival: 12.2 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: United States
City/State/Province: Philadelphia, PA
Hospital: Fox Chase Cancer Center
Journal: Link
Date: 8/2005

Patients: This Phase II study involved 30 patients, of which 27 were evaluated. The median age was 61. 23 patients had ovarian cancer and 4 had primary peritoneal cancer.

Treatment: The treatment consisted of one chemotherapeutic drug: gefitinib.

Toxicity: Grade 3-4 toxicities were neutropenia, gastrointestinal (diarrhea, nausea, emesis) and dermatological.

Results: The overall survival was 12.2 months. The authors concluded: "Gefitinib was well tolerated but had minimal activity in unscreened patients with recurrent ovarian or primary peritoneal carcinoma."

Correspondence: Dr. Russell J. Schilder, MD

E-mail to a Friend Email Physician More Information